Document:

Exhibit 10.9

 

[●], 2021

 

Chardan NexTech Acquisition 2 Corp.

17 State Street, 21st Floor

New York, NY 10004

Ladies and Gentlemen:

 

Chardan NexTech Acquisition
2 Corp. (the “Company”), a blank check company formed for the purpose of acquiring one or more businesses or entities
(a “Business Combination”), intends to register its securities under the Securities Act of 1933, as amended (“Securities
Act”), in connection with its initial public offering (“IPO”), pursuant to a registration statement on Form
S-1 (“Registration Statement”).

 

The undersigned hereby commits
that it will purchase an aggregate of 4,200,000 (or up to 4,385,185, depending on the extent to which the underwriters’ over-allotment
option is exercised) warrants of the Company (“Private Warrants”), at a price of $0.81 per warrant for an aggregate
purchase price of $3,402,000 (or up to $3,552,000, depending on the extent to which the underwriters’ over-allotment option is
exercised) (the “Private Warrant Purchase Price”).

 

The consummation of the purchase
and issuance of the Private Warrants shall occur simultaneously with the consummation of the IPO. Simultaneously with the consummation
of the IPO, Continental Stock Transfer & Trust Company shall deposit the Private Warrant Purchase Price, without interest or deduction,
into the trust fund (“Trust Fund”) established by the Company for the benefit of the Company’s public stockholders
as described in the Registration Statement.

 

Additionally, the undersigned
agrees:

 

	 	·	not to propose, or vote in favor of, an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of the Company’s shares of common stock, par value $0.0001 per share (the “Common Stock”) sold in the IPO if the Company does not complete an initial Business Combination within 24 months from the closing of the IPO, unless the Company provides the holders of shares of Common Stock sold in the IPO with the opportunity to redeem their shares of Common Stock upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount of the Trust Fund, including interest earned on Trust Fund and not previously released to the Company to pay the Company’s franchise and income taxes, divided by the number of then outstanding shares of Common Stock sold in the IPO;

 

	 	·	the undersigned will not participate in any liquidation distribution with respect to the Private Warrants (but will participate in liquidation distributions with respect to any units or Common Stock purchased by the undersigned in the IPO or in the open market) if the Company fails to consummate a Business Combination;

 

    	 	 

     

    

 

	 	
    ·

     
	
    that the Private Warrants and underlying
securities will not be transferable or saleable until 30 days after the consummation of a Business Combination except ((a) to the
Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members
of the undersigned, Chardan NexTech Investments 2 LLC (“Sponsor”), or any of their respective affiliates; (b) in
the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is
a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case
of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual,
pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of
an initial Business Combination at prices no greater than the price at which the shares or warrants were originally purchased; (f) in
the event of the Company’s liquidation prior to the completion of an initial Business Combination; or (g) by virtue of the
laws of Delaware or the applicable limited liability company agreement upon dissolution of the undersigned, provided, however, that in
the case of clauses (a) through (e) or (g), these permitted transferees must enter into a written agreement agreeing to be
bound by these transfer restrictions and the other restrictions contained in the letter agreements and by the same agreements entered
into by the undersigned, Sponsor, officers, and directors of the Company, as the case may be, with respect to such securities (including
provisions relating to voting, the trust account and liquidation distributions described elsewhere in this prospectus);

	 	 	 

	 	·	Private Warrants and underlying securities are considered underwriting compensation and, as provided in FINRA Rule 5110(e)(1), may not be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities for a period of 180 days immediately following the date of effectiveness of the Registration Statement, except as provided in FINRA Rule 5110(e)(2); and

 

	 	·	the Private Warrants will include any additional terms or restrictions as is customary in other similarly structured blank check company offerings or as may be reasonably required by the underwriters in the IPO in order to consummate the IPO, each of which will be set forth in the Registration Statement.

 

The undersigned acknowledges
and agrees that the purchaser of the Private Warrants will execute agreements in form and substance typical for transactions of this nature
necessary to effectuate the foregoing agreements and obligations prior to the consummation of the IPO as are reasonably acceptable to
the undersigned, including but not limited to an insider letter.

 

The undersigned hereby represents
and warrants that:

 

(a)
it has been advised that the Private Warrants have not been registered under the Securities Act;

 

(b)
it will be acquiring the Private Warrants for its account for investment purposes only;

 

(c)
it has no present intention of selling or otherwise disposing of the Private Warrants in violation of the securities laws of the
United States;

 

(d)
it is an “accredited investor” as defined by Rule 501 of Regulation D promulgated under the Securities Act of 1933,
as amended;

 

(e)
it has had both the opportunity to ask questions and receive answers from the officers and directors of the Company and all persons
acting on its behalf concerning the terms and conditions of the offer made hereunder;

 

(f)
it is familiar with the proposed business, management, financial condition and affairs of the Company;

 

(g)
it has full power, authority and legal capacity to execute and deliver this letter and any documents contemplated herein or needed
to consummate the transactions contemplated in this letter; and

 

(h)
this letter constitutes its legal, valid and binding obligation, and is enforceable against it.

 

This letter agreement constitutes
the entire agreement between the undersigned and the Company with respect to the purchase of the Private Warrants, and supersedes all
prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with respect to the same.

 

    	 	 

     

    

 

	 	 	
    

    Very truly yours,

	 	 	CHARDAN NEXTECH 2 WARRANT HOLDINGS LLC
	 	 	 	 
	 	 	By:	 
	 	 	 	Name: [●]
	 	 	 	Title: [●]

 

	Accepted and Agreed:	 	 	 
	CHARDAN NEXTECH ACQUISITION 2 CORP.	 	 	 
	 	 	 	 	 
	By:	 	 	 	 
	 	Name: Jonas Grossman	 	 	 
	 	Title: President and Chief Executive OfficerExhibit 10.6.1

 

FIRST
AMENDMENT

TO

LOAN AND SECURITY AGREEMENT

 

THIS
FIRST AMENDMENT to Loan and Security Agreement (this “Amendment”) is entered into as of June 30, 2021 by and among
(a) SILICON VALLEY BANK, a California corporation (“SVB”), in its capacity as administrative agent and collateral
agent (“Agent”), (b) SVB, as a lender, (c) SVB INNOVATION CREDIT FUND VIII, L.P., a Delaware limited partnership (“SVB
Capital”), as a lender (SVB and SVB Capital and each of the other “Lenders” from time to time a party hereto are referred
to herein collectively as the “Lenders” and each individually as a “Lender”), and (d) HUMACYTE,
INC., a Delaware corporation (“Humacyte” and together with any other entity executing a joinder to the Loan Agreement
(as defined below) as a borrower (including SPAC Parent after the closing of the SPAC Transaction), individually and collectively, jointly
and severally, “Borrower”).

 

Recitals

 

A.
Agent, Lenders, and Borrower have entered into that certain Loan and Security Agreement dated as of March 30, 2021 (as the same may
from time to time be amended, modified, supplemented or restated, the “Loan Agreement”). Lenders have extended credit to
Borrower for the purposes permitted in the Loan Agreement.

 

B.
Borrower has requested that Agent and Lenders amend the Loan Agreement to (i) revise the definition of “Cash Collateralization
Event” set forth therein and (ii) make certain other revisions to the Loan Agreement as more
fully set forth herein.

 

C.
Agent and Lenders have agreed to so amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the
terms, subject to the conditions and in reliance upon the representations and warranties set forth below.

 

Agreement

 

Now,
Therefore,
in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged,
and intending to be legally bound, the parties hereto agree as follows:

 

1.
Definitions.
Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Loan Agreement.

 

     

     

    

 

2.
Amendments to Loan Agreement. 

 

2.1
Section 6.13 (Cash Collateralization Trigger). Section 6.13 of the Loan Agreement hereby is amended and restated in its entirety
to read as follows:

 

“6.13
Cash Collateralization Trigger. If a Cash Collateralization Event occurs at any time prior to repayment in full of all Obligations
(other than inchoate indemnity obligations and any Obligations under Bank Services Agreements), Borrower hereby authorizes and directs
Agent to immediately transfer to account number XXX-XXX-7530 held at SVB (the “Pledged Account”) (from any one or
a combination of Borrower’s accounts at SVB) an aggregate amount of cash and/or Cash Equivalents equal to fifty percent (50%) of
the then-outstanding principal balance of and interest accrued on the Term Loan Advances in order to cash collateralize all amounts owing
from Borrower to the Lenders in connection with the Term Loan Advances (a “Cash Collateralization”), it being understood
that the foregoing authorization shall constitute an immediate Cash Collateralization of the Obligations, irrespective of any delay by
Agent in effecting such transfer. For purposes hereof “Cash Collateralization Event” means Borrower fails to consummate
the Equity Event by July 9, 2021. If, subsequent to the Cash Collateralization Event, an Equity Event shall be consummated, then (i)
the Cash Collateralization requirements described in the immediately foregoing sentence shall no longer apply and (ii) Agent shall, and
is hereby authorized and directed to, immediately transfer all funds in the Pledged Account to the Designated Deposit Account.”

 

3.
Limitation of Amendments.

 

3.1
The amendments set forth in Section 2, above, are effective for the purposes set forth herein and shall be limited precisely
as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any
Loan Document, or (b) otherwise prejudice any right or remedy which Agent and/or any Lender may now have or may have in the future under
or in connection with any Loan Document.

 

3.2
This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations,
warranties, covenants and agreements set forth in the Loan Documents, except as herein amended, are hereby ratified and confirmed and
shall remain in full force and effect.

 

4.
Representations and Warranties.
To induce Agent and Lenders to enter into this Amendment, Borrower hereby represents and warrants to Agent and Lenders as follows:

 

4.1
Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true,
accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate
to an earlier date, in which case they are true, accurate and complete as of such date), and (b) no Event of Default has occurred and
is continuing;

 

4.2
Borrower has the power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement,
as amended by this Amendment;

 

4.3
The organizational documents of Borrower delivered to Agent on the Effective Date remain true, accurate and complete and have not
been amended, supplemented or restated and are and continue to be in full force and effect;

 

4.4
The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement,
as amended by this Amendment, have been duly authorized;

 

4.5
The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement,
as amended by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual
restriction with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental or public body or
authority, or subdivision thereof, binding on Borrower, or (d) the organizational documents of Borrower;

 

    2

     

    

 

4.6
The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement,
as amended by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording
or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower, except
as already has been obtained or made; and

 

4.7
This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower
in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium
or other similar laws of general application and equitable principles relating to or affecting creditors’ rights.

 

5.
Ratification of Perfection Certificate.
Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures contained in a certain Perfection Certificate
dated on or prior to the Effective Date and acknowledges, confirms and agrees that the disclosures and information Borrower provided
to Agent in such Perfection Certificate have not changed, as of the date hereof.

 

6.
Counterparts.
This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute
one and the same instrument.

 

7.
Effectiveness.
This Amendment shall be deemed effective upon (a) the due execution and delivery to Agent and Lenders of (i) this Amendment by each party
hereto, and (ii) an updated Borrowing Certificate by Borrower, and (b) Borrower’s payment of all Lenders’ Expenses due and
owing as of the date hereof, which may be debited from any of Borrower’s accounts at SVB.

 

8.
Miscellaneous.

 

8.1
This Amendment shall constitute a Loan Document under the Loan Agreement; the failure to comply
with the covenants contained herein shall constitute an Event of Default under the Loan Agreement (subject to certain grace and cure
options set forth in Section 8 of the Loan Agreement); and all obligations included in this Amendment (including, without limitation,
all obligations for the payment of principal, interest, fees, and other amounts and expenses) shall constitute obligations under the
Loan Agreement and secured by the Collateral.

 

8.2
Each provision of this Amendment is severable from every other provision in determining the
enforceability of any provision.

 

9.
Governing Law.
This Amendment and the rights and obligations of the parties hereto shall be governed by and construed in accordance with the laws of
the State of New York.

 

[Balance
of Page Intentionally Left Blank]

 

    3

     

    

 

In
Witness Whereof, the parties hereto have caused this
Amendment to be duly executed and delivered as of the date first written above.

 

	BORROWER:	 
	 	 	 
	HUMACYTE, INC.	 
	 	 	 
	By:	 /s/ Dale Sander	 
	Name: 	Dale Sander	 
	Title:
    	Chief Financial Officer	 
	 	 	 
	AGENT:	 
	 	 	 
	SILICON
    VALLEY BANK, as Agent	 
	 	 	 
	By:	 /s/ Scott McCarty	 
	Name:
    	Scott McCarty	 
	Title:	Director	 
	 	 	 
	LENDERS:	 
	 	 	 
	SILICON
    VALLEY BANK, as Lender	 
	 	 	 
	By:	 /s/ Scott McCarty	 
	Name:	Scott McCarty	 
	Title:
    	Director	 

 

	SVB
    INNOVATION CREDIT FUND VIII, L.P., 	 
	 	 
	By:
    	SVB
    Innovation Credit Partners VIII, LLC, a 	 
	 	Delaware
    limited liability company, its General	 
	 	Partner,
    as Lender	 

 

	By:	 /s/ Ryan Grammer	 
	Name: 
    	Ryan Grammer	 
	Title:	Senior Managing Director	 

 

[Signature
Page to First Amendment to Loan and Security Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]